d-Xylose C14 use while Breastfeeding

Summary of Use during Lactation

Information in this record refers to the use of d-xylose C 14 as a diagnostic agent. Breastfeeding does not need to be suspended after administration of d-xylose C 14.[1,2]

Drug Levels

Carbon 14 is a low-energy beta emitter with a physical half-life of about 5730 years.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

References

1.

Leide-Svegborn S, Ahlgren L, Johansson L, et al. Excretion of radionuclides in human breast milk after nuclear medicine examinations. Biokinetic and dosimetric data and recommendations on breastfeeding interruption. Eur J Nucl Med Mol Imaging 2016;43:808-21. [PubMed: 26732471]

2.

Mattsson S, Johansson L, Leide Svegborn S, et al. Radiation dose to patients from radiopharmaceuticals: A compendium of current information related to frequently used substances. Annex D. Recommendations on breast-feeding interruptions. Ann ICRP 2015;44 (2 Suppl):319-21. [PubMed: 26069086]

Substance Name

d-Xylose C14

Drug Class

Breast Feeding

Lactation

Milk, Human

Radiopharmaceuticals

Carbon Radioisotopes

Diagnostic Agents